Business Wire

Movie Industry Welcomes New POWSTER Labs Team

Jaa

POWSTER, the creative studio that works with over 100 movie distributors including all six major studios, has announced a brand new division named POWSTER Labs. The team of highly skilled, creative experts based in Los Angeles will power up studios’ movie-marketing campaigns. POWSTER Labs is already aiming high, allowing moviegoers to detect the moon in their mobile web browser to activate an Augmented Reality experience for Universal Pictures’ First Man, starring Ryan Gosling. The creative marketing asset takes users on a journey to the moon while accessing behind-the-scenes footage and exclusive clips from the movie. The specialized division will pioneer developments in interactive VFX Breakdowns, interactive WebGL, 3D galleries, and interfacing with new APIs and effects released by publishers and social networks. POWSTER Labs comprises a dedicated, full-time innovation team assembled to create award-winning client campaigns, that will add new value to the entertainment industry.

POWSTER is known to redefine what is possible in digital marketing for the entertainment industry. The AR asset created by POWSTER Labs for Universal Pictures’ First Man breaks the barriers of what can be used as an AR tracker by reshaping the software’s capacity for image recognition. POWSTER is recognized for several other world firsts, including the award-winning VFX Breakdown for Pacific Rim: Uprising, which went on to win FWA Site of the Day. Audio isolation was achieved in the 360 video created for John Williams: A Life in Music, the video was honored with a Lovie Award for experimental, innovation in social media. The interactive music video engineered for “Work it Out” by Netsky has been honored as Adobe’s Cutting Edge Project of the Month. POWSTER’s creative campaign to promote the launch of Newton Faulkner’s fourth album Studio Zoo gave fans intimate access to Faulkner’s creative process via a live stream of his studio and the ability to interact with the artist on social media and control his house with Twitter. The project was named one of Google Sandbox’s Campaigns of the Year.

POWSTER Labs will continue to engineer the most innovative marketing tools available, optimized with ticket sales in mind. POWSTER CEO, Ste Thompson comments, “We are constantly pushing forward and keeping up with the way digital is changing, and I think that’s our unique quality. We aren’t just business people pushing a product, we are inventors looking at the future and constantly building new things.”

POWSTER also creates over 150 official movie destinations per month, powering ticketing websites for some of the largest blockbuster movies. Founded in London in 2009 as a sole proprietorship, Mr. Thompson sold a portion of the company to Vista Group in 2017 and expanded operations to a second studio in Los Angeles. Now, with a dedicated team housed in the same city as the major studios, there will be further innovation led by the needs of those studios. POWSTER Labs is inventing new methods of interactive storytelling; visit https://moon.firstman.com/ on your mobile browser to experience POWSTER Labs’ first mission; AR track the moon.

About POWSTER

POWSTER, part of Vista Group International (NZX & ASX: VGL), is a creative and innovation studio operating in London and Los Angeles. The business provides creative services to the film and music industry and creates products to help engage users with entertainment content. The global leader in film distribution marketing websites, POWSTER creates more than 150 destinations a month for 100+ movie distributors in over 40 countries. The POWSTER movie platform enables over five million consumers a week to discover cinema show times on official movie websites. POWSTER is modernizing how movies are marketed and delivering innovation to digital entertainment content. The future of movie marketing and interactive storytelling is coming soon.

About FIRST MAN

On the heels of their six-time Academy Award®-winning smash, La La Land, Oscar®-winning director Damien Chazelle and star Ryan Gosling reteam for Universal Pictures’ First Man , the riveting story behind the first manned mission to the moon, focusing on Neil Armstrong and the decade leading to the historic Apollo 11 flight. A visceral and intimate account told from Armstrong’s perspective, based on the book by James R. Hansen, the film explores the triumphs and the cost—on Armstrong, his family, his colleagues and the nation itself—of one of the most dangerous missions in history. www.firstman.com

First Man Creative: https://moon.firstman.com/
Website: https://labs.powster.com/
LinkedIn: www.linkedin.com/company/powster

Contact information

POWSTER
Samantha Robinson, (248) 721-2025
samantha@powster.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Age, Gender, Disease Severity Impact Adherence to Long-Term PAP Therapy More Than Previously Thought19.5.2019 22:15:00 EESTTiedote

ResMed (NYSE: RMD, ASX: RMD) today revealed several demographic and clinical factors affect adherence to PAP (positive airway pressure) therapy, according to a study it presented at the American Thoracic Society's ATS 2019 International Conference. The study found significant differences in one-year adherence between people of different ages and disease severity levels: Men with sleep apnea are 8.5 percentage points more likely to stay adherent on PAP therapy than women. People over age 60 were 7.3 percentage points more adherent than the entire study cohort (77.7% vs. 70.4%). People with self-reported severe sleep apnea were 78% adherent at the one-year mark, compared to 70.5% of those with self-reported moderate sleep apnea, and 65.2% of those with mild sleep apnea. “Sleep specialists, pulmonologists, and primary care physicians should heed these results and ensure that their younger, female, and more mildly diagnosed patients have the proper supports to stay on therapy,” said Adam B

Workiva Named Best-In-Class Cloud Service Provider at UK Cloud Awards17.5.2019 15:00:00 EESTTiedote

Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, was named the Best-In-Class Cloud Service Provider by the UK Cloud Awards 2019 at a ceremony here last night. Now in its sixth year, the UK Cloud Awards recognise innovation and excellence in the cloud industry by showcasing leading companies, customers and individuals in the United Kingdom. Workiva was recognised for its Wdesk platform that helps organisations consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders. Workiva, the global leader in XBRL and Inline XBRL, is also streamlining how customers comply with the European Securities and Markets Authority's mandate for Inline XBRL for European Single Electronic Format (ESEF) reporting. More than 5,000 EU issuers will be required to use ESEF taxonomy for their annual financial reports, ending on or after Jan

Novaremed Presents Top-Line Results from Phase 2a Diabetic Neuropathic Pain Study of NRD.E1 at NeuPSIG 201917.5.2019 13:13:00 EESTTiedote

Novaremed AG, a clinical-stage Swiss biopharmaceutical company, today announced a poster presentation highlighting the top-line results from a Phase 2a (Proof of Concept) study of NRD.E1 for the treatment of diabetic neuropathic pain (DNP). The poster presentation took place at the 7th International Congress on Neuropathic Pain Meeting (NeuPSIG) in London, UK on May 9-11, 2019. “This was our first communication at a leading neuropathic pain-focused event. Novaremed’s lead drug, NRD.E1 is a non-opioid small molecule for the treatment of neuropathic pain. The results of our Phase 2a in patients with DNP showed clinically relevant treatment benefit from NRD.E1 across multiple primary and secondary endpoints, providing a strong scientific foundation for advancing the development of NRD.E1 into the upcoming global Phase 2b study in DNP,” said Sara Mangialaio, Head of R&D and Chief Medical Officer of Novaremed AG. “NRD.E1 has the potential to address a major unmet medical need in DNP.” Poste

WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology17.5.2019 12:38:00 EESTTiedote

The 11th WIN Symposium in Precision Oncology will be held in Paris, France on June 23-24, 2019. ASCO® endorsed for the past 11 years, the WIN symposium will deliver an exciting line-up of speakers in Paris (France) on June 23-24, 2019 to discuss Innovation and Global Deployment of Precision Oncology. The current status of Precision Oncology across the globe will be examined with the exceptional participation of the chairmen of the event, Richard L. Schilsky, Chairman WIN Consortium(*), Senior Vice-President and Chief Medical Officer of ASCO, and Josep Tabernero, Vice Chairman WIN Consortium, President of ESMO and Director of Vall d’Hebron Institute of Oncology, Spain. Global experience will be shared: Optimizing Patient Enrollment and Efficacy of Precision Oncology Clinical Trials at UT MD Anderson Cancer Center, USA Decision Support for Precision Oncology: Evolving from Monotherapy to Genomically Informed Combinations, UT MD Anderson Cancer Center, USA The Value of Personalized Medici

Corsearch Acquires Principium Trademark Watch and Domain Services Businesses17.5.2019 11:00:00 EESTTiedote

Corsearch, the global brand creation, clearance, and protection leader, is pleased to announce the acquisition of the Principium Strategies trademark watch and domain services businesses, the brand protection subsidiary of Ladas and Parry LLP, a leader in global intellectual property law. The acquisition is effective immediately, solidifying and expanding Corsearch’s full-service trademark solutions offering for clients and brands globally. Principium is Corsearch’s third acquisition since becoming a standalone company in January 2018. The acquisition brings Corsearch’s employee count to more than 350 operating in 28 locations worldwide and adds valuable industry expertise and additional capabilities to Corsearch. “This is another really exciting acquisition for our business and a step forward in the evolution of Corsearch,” said Stephen Stolfi, Chief Commercial Officer of Corsearch. “Principium has provided clients with industry-leading trademark watching services for over 80 years an

CNT Among SAP’s "Best of the Best"17.5.2019 11:00:00 EESTTiedote

Since 2005, SAP is honoring the best of the best SAP projects yearly in Europe, Middle East and Africa. In 2018, 280 customers from 15 markets submitted their regional Gold Award-winning projects. CNT Management Consulting from Vienna won Bronze twice – together with its customers HOERBIGER and TANNPAPIER – a happy day for CNT’s CEO Andreas Doerner. "We are now on the podium for the second time with two projects – thanks to the trust of our customers." The SAP Quality Awards EMEA were presented at an exceptionally festive ceremony in Heidelberg Castle (Baden-Wuerttemberg), and only twelve SAP customers were able to take home the most wanted trophies that were presented by SAP Presidents Brian Duffy (EMEA North) and Hartmut Thomsen (Middle and Eastern Europe). The jury evaluated the projects according to the ten SAP quality principles and the question of whether the respective project could fulfill the expectations of its clients. HOERBIGER - Category Business Transformation Headquarter

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme